These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30703821)

  • 1. Low-Molecular-Weight Heparin in Cancer Patients: Overview and Indications.
    Voigtlaender M; Langer F
    Hamostaseologie; 2019 Feb; 39(1):67-75. PubMed ID: 30703821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
    Vedovati MC; Giustozzi M; Becattini C
    Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuation of low-molecular-weight heparin treatment for cancer-related venous thromboembolism: a prospective cohort study in daily clinical practice.
    van der Wall SJ; Klok FA; den Exter PL; Barrios D; Morillo R; Cannegieter SC; Jimenez D; Huisman MV
    J Thromb Haemost; 2017 Jan; 15(1):74-79. PubMed ID: 28012224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Treatment of Venous Thromboembolism in Patients with Cancer.
    Prandoni P
    Adv Exp Med Biol; 2017; 906():123-135. PubMed ID: 27620308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of venous thromboembolism in patients with cancer.
    Prandoni P
    Intern Emerg Med; 2010 Oct; 5 Suppl 1():S27-30. PubMed ID: 20865471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.
    den Exter PL; Kooiman J; van der Hulle T; Huisman MV
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):163-9. PubMed ID: 23953904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer.
    Walenga JM; Lyman GH
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):1-18. PubMed ID: 23849978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
    Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF
    J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous thromboembolism with tinzaparin in oncological patients.
    Ageno W; Barni S; Di Nisio M; Falanga A; Imberti D; Labianca RF; Mantovani L
    Minerva Med; 2019 Jun; 110(3):251-258. PubMed ID: 30990000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer.
    Lyman GH
    Cancer; 2009 Dec; 115(24):5637-50. PubMed ID: 19827150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
    van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
    Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
    Tran QN
    Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of venous thromboembolic disease in cancer patients].
    Farge-Bancel D; Florea L; Bosquet L; Debourdeau P
    Pathol Biol (Paris); 2008 Jun; 56(4):220-8. PubMed ID: 18394821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
    Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Venous thrombo-embolic disease in cancer. Low molecular weight heparin indications].
    Nou M; Laroche JP
    J Mal Vasc; 2016 May; 41(3):197-204. PubMed ID: 27146099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in patients with cancer: an overview for pharmacists using a case-based approach.
    Pangilinan JM
    J Pharm Pract; 2010 Aug; 23(4):294-302. PubMed ID: 21507829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of venous thromboembolism treatment in patients with cancer on low molecular weight heparin, warfarin, and the direct oral anticoagulants.
    Uppuluri EM; Burke KR; Haaf CM; Shapiro NL
    J Oncol Pharm Pract; 2019 Mar; 25(2):261-268. PubMed ID: 28942721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism. What do we know so far?
    Voigtlaender M; Langer F
    Hamostaseologie; 2017 Oct; 37(4):241-255. PubMed ID: 28508916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LMWH in cancer patients with renal impairment - better than warfarin?
    Bauersachs RM
    Thromb Res; 2016 Apr; 140 Suppl 1():S160-4. PubMed ID: 27067971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.